Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02428127
Other study ID # 203093
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2015
Est. completion date May 30, 2015

Study information

Verified date August 2018
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the impact of a beverage containing carbohydrate powder fortified with micronutrients on agility, speed, and power in school going children


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 30, 2015
Est. primary completion date May 1, 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 15 Years
Eligibility Inclusion Criteria:

- Informed consent by participant's parents or legally accepted representative

- Good general health

- Non anemic children (Hb=12 g/dl)

- Academy/development level athlete (at least 3 activity sessions per week, for a minimum of 2 hours of activity in each session e.g. hockey, football, team sports)

Exclusion Criteria:

- Child in care

- Allergy/Intolerance to study materials

- History of cardiovascular disorder, respiratory diseases, diabetes mellitus, serious infection/injuries/surgeries (within past 3 months)

- Participation in any nutritional study in past 1 year

- Substance abuse

- Children on any kind of medication in past 1 month of screening

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Carbohydrate beverage powder
Carbohydrate beverage powder fortified with multiple micronutrients. 20g of study product will be administered orally twice a day
Calorie matched beverage powder
Calorie matched beverage powder with 80% protein.20g of study product will be administered orally twice a day
Other:
Water
lukewarm water

Locations

Country Name City State
India GSK Investigational Site Pune

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

India, 

References & Publications (1)

http://www.i-scholar.in/index.php/Ijnd/article/view/130266

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Agility fatigue index Agility fatigue index (FI) will be calculated from Repeat Agility Performance Test, using 'Brower equipment'. This assessment includes a 24 meter agility run, repeated on 6 occasions, with every sprint and recovery interval lasting for 65 seconds (eg. if the first agility effort takes the participant 5 seconds, they will have 55 seconds to return to start line for a 5 seconds countdown before their second agility effort). Agility FI=[100X(total agility timeĆ·ideal agility time)]-100. Here, ideal agility time is the best agility time for each participant multiplied by number of repetitions Baseline and 4h post-baseline
Secondary Change from baseline in Speed fatigue index Speed fatigue index (FI) will be calculated from Repeat Sprint Performance Test, using 'Brower equipment'. This assessment includes a 30 meter sprint, repeated on 6 occasions, with every sprint and recovery interval lasting for 65 seconds (eg. if the first sprint takes the participant 5 seconds, they will have 55 seconds to return to start line for a 5 second countdown before their second sprint). Speed FI=[100X(total speed timeĆ·ideal speed time)]-100. Here, ideal speed time is the best speed time for each participant multiplied by number of repetitions Baseline and 4h post-baseline
Secondary Change from baseline in Mean power output Mean power output (MPO) will be calculated from Wingate Anaerobic Test, using 'Cycle ergometer'. The participant is allowed to pedal at a constant pace, without resistance and then with additional weights (resistance). This is repeated on three occasions. Overall MPO=(sum of MPO from 3 repetitions at baseline)-(sum of MPO from 3 repetitions at post treatment). Baseline and 4h post-baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05370989 - Technology-Based Parent School Program N/A
Recruiting NCT05138276 - Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates Early Phase 1
Completed NCT02345187 - fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation. N/A
Completed NCT04624347 - NEOVIDEO : Impact of Monitoring Motor Activity by Video Analysis on the Sleep of Very Preterm Infants N/A
Completed NCT03155269 - To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention N/A
Completed NCT02437721 - Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants N/A
Completed NCT02428699 - Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil N/A
Completed NCT03395015 - Efficacy of Maxillo-facial Treatment on Cleft Lip and Palate Patients Faces: Aesthetic Considerations N/A
Withdrawn NCT02551627 - A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children N/A
Completed NCT02542865 - A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children N/A
Completed NCT02805192 - Validation of a Smart Phone App to Non-invasively Measure the Size of Children N/A
Active, not recruiting NCT03099837 - Tongji Maternal and Child Health Cohort
Completed NCT03519503 - Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety
Completed NCT02254460 - Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk N/A
Completed NCT02338609 - Long-term Follow-up for Growth and Development of Pediatric Patients From CRAD001M2301 Phase 4
Recruiting NCT05868408 - Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants N/A